Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts say it's a much-needed, long-awaited tool — and they're pushing to make it ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
Science Africa on MSN10h
Yearly Injectable PrEP Promising in HIV PreventionBy Gift BritonThe once-a-year injectable pre-exposure prophylaxis (PrEP), Lenacapavir, has shown promising results in a recent Phase 1 clinical trial.The trial involved 40 healthy adults aged between ...
Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is largely due to excitement over its [long-acting HIV prevention drug]( ...
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the ...
Federal money is used for outreach to people who are vulnerable for HIV and helps cover testing as well as many other ...
If the preference for absolute freedom over the free person is a fact of the sexual revolution, the present time is as much at the height of this phenomenon as the 1960s was. However, today, we can’t ...
WISN 12 News on MSN2d
As Trump administration considers shuttering CDC HIV prevention division, local providers brace for changesIf the Trump administration follows through on plans to eliminate the Centers for Disease Control and Prevention's HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback